洞察眼睛遗传学和眼睛基因疗法的最新进展
Viktória Szabó1, Balázs Varsányi2, Mirella Barboni3
1Semmelweis University, Department of Ophthalmology, Mária Str. 39, Budapest, 1085, Hungary.
Molecular and cellular probes
|January 13, 2025
概括
基因疗法为遗传性眼睛疾病提供了新的希望,例如遗传性视网膜发育不良. 遗传学和诊断学的进步正在个性化治疗,正在研究新的策略和技术.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 基因疗法正在迅速发展为遗传性疾病.
- 眼科疾病,特别是遗传性视网膜变,是基因疗法发展的重点.
- 这些疾病导致视力丧失,并使用先进的成像和遗传检测进行诊断.
研究的目的:
- 审查眼科疾病的遗传学.
- 为突出批准和新兴的眼科基因疗法.
- 讨论眼部基因疗法的挑战和未来方向.
主要方法:
- 关于遗传眼病和基因治疗策略的文献综述.
- 对已批准的眼科基因疗法和正在进行的研究进行分析.
- 在眼科中讨论载体系统,CRISPR/Cas9和个性化医疗.
主要成果:
- 遗传性视网膜衰变有不同的遗传原因和临床特征.
- 多式成像和分子诊断改善了疾病的理解和患者分层.
- 各种病毒和非病毒载体,以及CRISPR/Cas9,正在探索用于眼部基因治疗.
结论:
- 基因疗法在治疗遗传性眼病方面具有重大前景.
- 个性化医疗方法正在彻底改变眼科.
- 长期的安全性和疗效数据对于基因疗法的临床转化至关重要.
相关概念视频
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Genetic Lingo
100.7K
Overview
100.7K


